Sale, Miguel ..

HRN: 25-37-02  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/04/2025
08/11/2025
IV
60mg
Q12
Pneumonia
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: